SCHEMBL19862173

SCHEMBL19862173

Cc1cccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)C3(c5ccccc5C=C4)c4ccccc4-c4cc5oc6ccccc6c5cc43)n2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I3 Q14994 1/20 0.35
PDK2 Q15119 1/20 0.34
SMN1; SMN2 Q16637 6/20 0.34
MAPT P10636 4/20 0.34
ABCB1 P08183 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
RAB9A P51151 6/20 0.33
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
NPC1 O15118 5/20 0.33
HPGD P15428 4/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
GAA P10253 1/20 0.33
RORC P51449 1/20 0.32
MAPK14 Q16539 1/20 0.32
ENPP3 O14638 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862162 0.97 NR1I3 (0.34) NR1I3PDK2SMN1; SMN2MAPTABCB1
SCHEMBL19862142 0.93 AHR (0.34) SMN1; SMN2MAPTRAB9AMEN1KMT2A
SCHEMBL19862175 0.93 AHR (0.33) SMN1; SMN2MAPTRAB9AMEN1KMT2A
SCHEMBL19862177 0.92 PLA2G2A (0.32) PDK2MAPTMEN1KMT2AHPGD
SCHEMBL20224414 0.91 PDK2 (0.40) NR1I3PDK2SMN1; SMN2MAPTABCB1
SCHEMBL19862115 0.91 AHR (0.33) SMN1; SMN2MAPTRAB9AMEN1KMT2A
SCHEMBL19862123 0.90 AHR (0.33) SMN1; SMN2MAPTRAB9AMEN1KMT2A
SCHEMBL19862164 0.89 PLA2G2A (0.31) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL19862179 0.89 KMT2A (0.36) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL19862174 0.89 KMT2A (0.35) SMN1; SMN2MAPTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ORC3, AOX1, RCOR3 NR1I3 496/4885PDK2 2964/4885SMN1; SMN2 3862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.